for semaglutide 2.4mg (Wegovy), reassessment at 6 months (NICE TA875)
Key Takeaways Semaglutides Indian patent expired on 20 March 2026, and generic versions now cost roughly 5090% less than branded Ozempic a big part of why the GLP-1 drugs cost in India has fallen so fast
Regular communication and flexibility optimize your experience
In our pursuit of clinical excellence, we're thrilled to introduce you to Zepbound, a groundbreaking GLP-1 drug with FDA approval for weight loss, and share how it seamlessly integrates with our expertise in tummy tucks, breast augmentation, mommy makeovers, and body contouring
On this strong plinth of looking ahead, we have successfully and repeatedly harnessed our R&D expertise in synthesizing complex molecules to produce complex injectables